Triana Biomedicines: Funding, Investors & Team (Sep 2026)
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease targets that are difficult to address with any other modality. Triana’s drug discovery engine is powered by high-resolution structural insights, state-of-the-art in silico tools, and bespoke chemical libraries. The research team has validated the best-in-class platform and initiated multiple programs across different disease areas.
Triana Biomedicines has raised $120M across 1 funding round on record, the most recent a Series B of $120M announced in Dec 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Triana Biomedicines Company Profile and Key Stats
Latest funding round on record: Dec 2025.
Triana Biomedicines Funding Rounds
Triana Biomedicines Founders and Leadership Team
No contact details are on record for this team yet.
Triana Biomedicines Funding Compared to Other Biotechnology Startups
Triana Biomedicines' latest round of $120M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Triana Biomedicines in Biotechnology and Lexington
Companies Similar to Triana Biomedicines
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Triana Biomedicines Funding FAQs
What does Triana Biomedicines do?
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease targets that are difficult to address with any other modality. Triana’s drug discovery engine is powered by high-resolution structural insights, state-of-the-art in silico tools, and bespoke chemical libraries. The research team has validated the best-in-class platform and initiated multiple programs across different disease areas.
How much funding has Triana Biomedicines raised?
Triana Biomedicines has raised $120M across 1 round on record. The most recent is a Series B of $120M announced in Dec 2025.
When did Triana Biomedicines last raise funding?
Triana Biomedicines' most recent funding round on record is a Series B of $120M, announced in Dec 2025.
Who founded Triana Biomedicines?
FundedIQ lists Milind Deshpande (Founder) at Triana Biomedicines.
Where is Triana Biomedicines headquartered?
Triana Biomedicines is based in Lexington, Massachusetts, United States.
How many employees does Triana Biomedicines have?
Triana Biomedicines is in the 51-100 employee band.
How does Triana Biomedicines' funding compare to other Biotechnology startups?
Triana Biomedicines' latest round of $120M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Triana Biomedicines Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Triana Biomedicines is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.